145 related articles for article (PubMed ID: 30396475)
1. Is melatonin effective for pruritus caused by liver disease?
Esmaeili A; Namazi S
Med Hypotheses; 2018 Dec; 121():177-179. PubMed ID: 30396475
[TBL] [Abstract][Full Text] [Related]
2. [Pruritus in liver disease. Pathogenesis and treatment].
Kremer AE; Maillette de Buy Wenniger L; Oude Elferink RP; Beuers U
Ned Tijdschr Geneeskd; 2011; 155(52):A4045. PubMed ID: 22217242
[TBL] [Abstract][Full Text] [Related]
3. Mediators of pruritus during cholestasis.
Oude Elferink RP; Kremer AE; Beuers U
Curr Opin Gastroenterol; 2011 May; 27(3):289-93. PubMed ID: 21451412
[TBL] [Abstract][Full Text] [Related]
4. Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions.
Kremer AE; van Dijk R; Leckie P; Schaap FG; Kuiper EM; Mettang T; Reiners KS; Raap U; van Buuren HR; van Erpecum KJ; Davies NA; Rust C; Engert A; Jalan R; Oude Elferink RP; Beuers U
Hepatology; 2012 Oct; 56(4):1391-400. PubMed ID: 22473838
[TBL] [Abstract][Full Text] [Related]
5. Safety considerations for the management of cholestatic itch.
Trivella J; Levy C
Expert Opin Drug Saf; 2021 Aug; 20(8):915-924. PubMed ID: 33836644
[No Abstract] [Full Text] [Related]
6. The molecular mechanism of cholestatic pruritus.
Oude Elferink RP; Kremer AE; Martens JJ; Beuers UH
Dig Dis; 2011; 29(1):66-71. PubMed ID: 21691108
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic acid is a potential mediator of cholestatic pruritus.
Kremer AE; Martens JJ; Kulik W; Ruëff F; Kuiper EM; van Buuren HR; van Erpecum KJ; Kondrackiene J; Prieto J; Rust C; Geenes VL; Williamson C; Moolenaar WH; Beuers U; Oude Elferink RP
Gastroenterology; 2010 Sep; 139(3):1008-18, 1018.e1. PubMed ID: 20546739
[TBL] [Abstract][Full Text] [Related]
8. Pruritus in patients with chronic liver disease and serum autotaxin levels in patients with primary biliary cholangitis.
Fujino H; Tanaka M; Imamura M; Morio K; Ono A; Nakahara T; Murakami E; Kawaoka T; Takahashi S; Miki D; Tsuge M; Hiramatsu A; Aikata H; Hayes CN; Chayama K
BMC Gastroenterol; 2019 Oct; 19(1):169. PubMed ID: 31651244
[TBL] [Abstract][Full Text] [Related]
9. Autotaxin, Pruritus and Primary Biliary Cholangitis (PBC).
Sun Y; Zhang W; Evans JF; Floreani A; Zou Z; Nishio Y; Qi R; Leung PS; Bowlus CL; Gershwin ME
Autoimmun Rev; 2016 Aug; 15(8):795-800. PubMed ID: 27019050
[TBL] [Abstract][Full Text] [Related]
10. Serum Autotaxin is a Marker of the Severity of Liver Injury and Overall Survival in Patients with Cholestatic Liver Diseases.
Wunsch E; Krawczyk M; Milkiewicz M; Trottier J; Barbier O; Neurath MF; Lammert F; Kremer AE; Milkiewicz P
Sci Rep; 2016 Aug; 6():30847. PubMed ID: 27506882
[TBL] [Abstract][Full Text] [Related]
11. Autotaxin activity has a high accuracy to diagnose intrahepatic cholestasis of pregnancy.
Kremer AE; Bolier R; Dixon PH; Geenes V; Chambers J; Tolenaars D; Ris-Stalpers C; Kaess BM; Rust C; van der Post JA; Williamson C; Beuers U; Oude Elferink RP
J Hepatol; 2015 Apr; 62(4):897-904. PubMed ID: 25450205
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in the management of pruritus in chronic liver diseases.
Tajiri K; Shimizu Y
World J Gastroenterol; 2017 May; 23(19):3418-3426. PubMed ID: 28596678
[TBL] [Abstract][Full Text] [Related]
13. [Management of pruritus in patients with cholestatic liver disease].
Kremer AE; Kraus MR
MMW Fortschr Med; 2016 Jun; 158(12):64-7. PubMed ID: 27324009
[No Abstract] [Full Text] [Related]
14. [Cholestatic pruritus : new insights into pathophysiology and current treatment].
Kremer AE; Oude Elferink RP; Beuers U
Hautarzt; 2012 Jul; 63(7):532-8. PubMed ID: 22733242
[TBL] [Abstract][Full Text] [Related]
15. Serum Autotaxin Activity Correlates With Pruritus in Pediatric Cholestatic Disorders.
Kremer AE; Gonzales E; Schaap FG; Oude Elferink RP; Jacquemin E; Beuers U
J Pediatr Gastroenterol Nutr; 2016 Apr; 62(4):530-5. PubMed ID: 26628447
[TBL] [Abstract][Full Text] [Related]
16. The Correlation Between the Autotaxin Enzyme and Pruritus in Egyptian Patients Suffering from Chronic Liver Disease.
Asal F; Ziada D; Wageh A; El-Kohy M; Hawash N; Abd-Elsalam S; Badawi R
Antiinflamm Antiallergy Agents Med Chem; 2021; 20(3):302-307. PubMed ID: 33459246
[TBL] [Abstract][Full Text] [Related]
17. The use of antihistamines with a low sedative potential in the treatment of the itching of atopic eczema.
Gibson JR
Clin Exp Dermatol; 1987 Nov; 12(6):469-70. PubMed ID: 2904843
[No Abstract] [Full Text] [Related]
18. Potentials of the circulating pruritogenic mediator lysophosphatidic acid in development of allergic skin inflammation in mice: role of blood cell-associated lysophospholipase D activity of autotaxin.
Shimizu Y; Morikawa Y; Okudaira S; Kimoto S; Tanaka T; Aoki J; Tokumura A
Am J Pathol; 2014 May; 184(5):1593-603. PubMed ID: 24641902
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis and Management of Pruritus in PBC and PSC.
Kremer AE; Namer B; Bolier R; Fischer MJ; Oude Elferink RP; Beuers U
Dig Dis; 2015; 33 Suppl 2():164-75. PubMed ID: 26641452
[TBL] [Abstract][Full Text] [Related]
20. Opioid antagonists in the treatment of pruritus from cholestatic liver disease.
Terra SG; Tsunoda SM
Ann Pharmacother; 1998 Nov; 32(11):1228-30. PubMed ID: 9825091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
